Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.15 USD | -3.44% | -0.24% | -9.47% |
Apr. 30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
Apr. 30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
Financials (USD)
Sales 2024 * | 712M | Sales 2025 * | 842M | Capitalization | 1.71B |
---|---|---|---|---|---|
Net income 2024 * | 141M | Net income 2025 * | 232M | EV / Sales 2024 * | 2 x |
Net cash position 2024 * | 292M | Net cash position 2025 * | 524M | EV / Sales 2025 * | 1.41 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
7.86
x | Employees | 246 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.66% |
Latest transcript on Harmony Biosciences Holdings, Inc.
1 day | -2.00% | ||
1 week | +1.26% | ||
Current month | -3.98% | ||
1 month | +2.88% | ||
3 months | -8.68% | ||
6 months | +2.24% | ||
Current year | -8.11% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Dayno
CEO | Chief Executive Officer | 66 | 17-10-31 |
Director of Finance/CFO | 54 | 21-03-28 | |
Kumar Budur
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Aronin
FOU | Founder | 56 | 17-07-24 |
R. Graf
BRD | Director/Board Member | 59 | 20-11-10 |
Andreas Wicki
BRD | Director/Board Member | 64 | 17-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.52% | 14 M€ | -3.15% | ||
0.35% | 28 M€ | -1.97% | ||
0.31% | 25 M€ | -1.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 29.25 | -3.11% | 97 764 |
24-05-22 | 30.19 | +1.82% | 287,263 |
24-05-21 | 29.65 | -0.24% | 334,307 |
24-05-20 | 29.72 | +2.38% | 374,331 |
24-05-17 | 29.03 | -0.96% | 334,571 |
Delayed Quote Nasdaq, May 23, 2024 at 11:16 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.11% | 1.71B | |
+39.70% | 723B | |
+34.28% | 595B | |
-3.72% | 369B | |
+20.30% | 332B | |
+2.79% | 282B | |
+17.13% | 244B | |
+9.14% | 208B | |
-5.07% | 205B | |
+0.04% | 168B |
- Stock Market
- Equities
- HRMY Stock